±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1039  |  »Ø¸´: 3
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

aloin

½ð³æ (СÓÐÃûÆø)

[½»Á÷] ÇóÖúÓ¢Ò뺺£¨5ÔÂ26ÈÕÖÐÎç12µãǰÍê³ÉÓÐЧ£©

1¡¢Irinotecan is an antineoplastic enzyme inhibitor primarily used in the treatment of colorectal cancer. Irinotecan is a derivative of camptothecin. Irinotecan inhibits the action of topoisomerase I. Irinotecan prevents religation of the DNA strand by binding to topoisomerase I-DNA complex, and causes double-strand DNA breakage and cell death.

2¡¢Decitabine is indicated for treatment of patients with myelodysplastic syndrome (MDS). It is a chemical analogue of cytidine, a nucleoside present in DNA and RNA. Cells in the presence of Decitabine incorporate it into DNA during replication and RNA during transcription. The incorporation of Decitabine into DNA or RNA inhibits methyltransferase thereby causing demethylation in that sequence. This adversely affects the way that cell regulatory proteins are able to bind to the DNA/RNA substrate.


3¡¢Pimecrolimus is a chemical that is used to treat atopic dermatitis (eczema). Atopic dermatitis is a skin condition characterized by redness, itching, scaling and inflammation of the skin. The cause of atopic dermatitis is not known; however, scientists believe that it may be due to activation of the immune system by various environmental or emotional triggers. Scientists do not know exactly how pimecrolimus reduces the manifestations of atopic dermatitis, but pimecrolimus reduces the action of T-cells and mast cells which are part of the immune system and contribute to responses of the immune system. Pimecrolimus prevents the activation of T-cells by blocking the effects of chemicals (cytokines) released by the body that stimulate T-cells. Pimecrolimus also reduces the ability of mast cells to release chemicals that promote inflammation.
4¡¢Temsirolimus is an inhibitor of mTOR (mammalian target of rapamycin). Temsirolimus binds to an intracellular protein (FKBP-12), and the protein-drug complex inhibits the activity of mTOR that controls cell division. Inhibition of mTOR activity resulted in a G1 growth arrest in treated tumor cells. When mTOR was inhibited, its ability to phosphorylate p70S6k and S6 ribosomal protein, which are downstream of mTOR in the PI3 kinase/AKT pathway was blocked. In in vitro studies using renal cell carcinoma cell lines, temsirolimus inhibited the activity of mTOR and resulted in reduced levels of the hypoxia-inducible factors HIF-1 and HIF-2 alpha, and the vascular endothelial growth factor.

5¡¢Everolimus is a derivative of Rapamycin (sirolimus), and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor. It is currently used as an immunosuppressant to prevent rejection of organ transplants. In a similar fashion to other mTOR inhibitors Everolimus' effect is solely on the mTORC1 protein and not on the mTORC2 protein.

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

aloin

½ð³æ (СÓÐÃûÆø)

ÈçÌ⣺5ÔÂ26ÈÕÖÐÎç12µãǰÍê³ÉÓÐЧ
2Â¥2010-05-25 23:15:11
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xaya1001

½ð³æ (СÓÐÃûÆø)

aloin(½ð±Ò+5, ·­ÒëEPI+1):лл 2010-05-26 10:22:55
ÎÒÖ»ÊÇÀ´Ñ§Ï°µÄ£¬Â¥Ö÷ºöÂÔÎÒ°É
antineoplastic¿¹Ö×ÁöµÄ
colorectal cancer´ó³¦°©
camptothecinϲÊ÷¼î
topoisomeraseÍØÆËÒ칹ø
religationÖØÐÂÁ¬½Ó  recombinantÖØ×é
DNA strand  DNAÁ´

myelodysplastic syndrome (MDS)¹ÇËèÔöÉúÒì³£×ÛºÏÕ÷£¬Ô­Ãû°×Ѫ²¡Ç°ÆÚpreleukemia
cytidine°ûà×ठ nucleosideºËÜÕ
incorporateºÏ²¢¡¢²ô½ø
replication¸´ÖÆ  transcriptionת¼
methyltransferase¼×»ù×ªÒÆÃ¸
adversely affects²»ÀûÓ°Ïì
regulatoryµ÷½Ú

atopic dermatitisÒìλÐÔÆ¤·ôÑ×
eczemaʪÕî

Ì«ÍíÁË
¶¼ÊÇЩҩƷ¼ò½é
3Â¥2010-05-26 00:51:30
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

jingjing1005

ľ³æ (СÓÐÃûÆø)

aloin(½ð±Ò+95):лл 2010-05-26 10:23:19
1ÒÁÁ¢Ì濵ÊÇÖ÷ÒªÓÃÓÚÖÎÁƽáÖ±³¦°©µÄøÒÖÖÆ¼Á¿¹Ö×ÁöÒ©¡£ÒÁÁ¢Ì濵ÊÇϲÊ÷¼îµÄÑÜÉúÎï¡£ÒÁÁ¢Ì濵ÒÖÖÆÍØÆËÒ칹øIµÄ»î¶¯£¬Í¨¹ýÐγÉÍØÆËÒ칹øI-DNA¸´ºÏÎï×èÖ¹DNAµ¥Á´Á¬½Ó³ÉË«Á´DNA£¬²¢µ¼ÖÂË«Á´DNA¶ÏÁÑ£¬×îÖÕµ¼ÖÂϸ°ûËÀÍö¡£

2 µØÎ÷Ëû±õÓÃÓÚÖÎÁƹÇËèÔöÉúÒì³£×ÛºÏÕ÷£¨MDS£©¡£ËüÊÇÒ»ÖÖ°ûवĻ¯Ñ§ÀàËÆÎ´æÔÚÓÚÔÚDNAºÍRNAµÄºËÜÕËáÖС£ÔÚµØÎ÷Ëû±õ´æÔÚʱ£¬Ï¸°û·Ö±ðͨ¹ý¸´Öƹý³ÌºÍת¼¹ý³Ì½«ËüÕûºÏµ½DNAºÍRNAÖУ¬´Ó¶øÒÖÖÆ¼×»ù×ªÒÆÃ¸µÄ»îÐÔ£¬µ¼Ö¸ÃÐòÁÐÍѼ׻ù»¯¡£ÕâÑÏÖØÓ°ÏìÁËϸ°ûµ÷½Úµ°°×ÓëDNA / RNA»ùÖʵĽáºÏ¡£

3ßÁÃÀĪ˾ÊÇÒ»ÖÖÓÃÓÚÖÎÁÆÌØÓ¦ÐÔÆ¤Ñ×£¨ÊªÕµÄÒ©Îï¡£ÒìλÐÔÆ¤Ñ×ͨ³£ÓÐÆ¤·ô·¢ºì£¬·¢Ñ÷£¬ÓãÁۺͷ¢Ñ×µÄÖ¢×´¡£ÌØÓ¦ÐÔÆ¤Ñ׵ķ¢²¡Ô­ÒòÉв»Çå³þ£¬µ«¿ÆÑ§¼ÒÈÏΪËü¿ÉÄÜÊÇÓÉÇéÐ÷ÒòËØ»ò¸÷ÖÖ»·¾³ÒòËØµ¼ÖµÄÃâÒßϵ¼¤»îÒýÆðµÄ¡£¿ÆÑ§¼Ò²¢²»ÖªµÀµ½µ×ßÁÃÀĪ˾ÊÇÈçºÎ»º½âÌØÓ¦ÐÔÆ¤Ñ×µÄÖ¢×´µÄ£¬µ«ßÁÃÀĪ˾¼õÉÙÁËTϸ°ûºÍ·Ê´óϸ°ûµÄ»î¶¯£¬ÕâЩϸ°ûÊÇÃâÒßϵͳµÄÒ»²¿·Ö£¬²¢ÔÚÃâÒßÓ¦´ð¹ý³ÌÖÐÆð×ÅÖØÒª×÷Óá£ßÁÃÀĪ˾¿ÉÒÔ×è¶ÏÈËÌå·ÖÃڵĻ¯Ñ§·Ö×Ó£¨Ï¸°ûÒò×Ó£©´Ì¼¤Tϸ°û»î»¯µÄ¹ý³Ì£¬Í¬Ê±Ëü»¹¿ÉÒÔÒÖÖÆ·Ê´óϸ°ûÊÍ·Å»¯Ñ§ÎïÖÊ£¬´Ó¶ø¼õÇáÑ×Ö¢Ö¢×´¡£
4£¬ÍÔÈðÈû¶ûTemsirolimusÊÇÒ»ÖÖmTOR(²¸È鶯ÎïµÄÀ×ÅÁÃ¹ËØ×÷Óðеã)ÒÖÖÆ¼Á£¬Ëü¿ÉÒÔÓëÒ»ÖÖϸ°ûÄÚµ°°×(FKBPÒ»12)Ïà½áºÏ£¬ÕâÖÖµ°°×-Ò©Îï½áºÏÎï¿ÉÒÔÒÖÖÆmTOR¿ØÖÆÏ¸°û·ÖÁÑ¡£ mTOR¿ÉÒÔÁ×Ëữ¼¤»îp70S6kºÍS6ºËÌÇÌåµ°°×£¬mTORÏÂÓÎÇøµÄÁ×Ö¬õ£¼¡´¼¼¤Ã¸£¯AKT(PI3K£¯AKT)ÐźÅתµ¼Í¨Â·±»×è¶Ïºó£¬Æä»îÐÔ½«Êܵ½ÒÖÖÆ¿ÉÒÔʹGÆÚµÄÖ×Áöϸ°ûÉú³¤Í£ÖÍ¡£²ÉÓÃÉö°©Ï¸°ûΪÑо¿¶ÔÏóµÄÌåÍâÑо¿±íÃ÷£¬ÍÔÈðÈû¶û¿ÉÒÔÒÖÖÆmTORµÄ»îÐÔ²¢ÇÒ½µµÍȱÑõÓÕµ¼Òò×ÓHIF¡ªl¡¢HIFÒ»2a¼°Ñª¹ÜÄÚÆ¤Éú³¤Òò×Óˮƽ¡£

5ÒÀάĪ˾ÊÇÀ×ÅÁÃ¹ËØÑÜÉúÎÎ÷ÂÞĪ˾£©£¬ÓëÀ×ÅÁĪ˾×÷ÓÃÏàËÆ£¬ÊÇmTOR£¨À×ÅÁĪ˾µÄ×÷Óðе㣩µÄÒÖÖÆ¼Á¡£Ä¿Ç°ÓÃ×÷ÃâÒßÒÖÖÆ¼Á£¬ÒÔ·ÀÖ¹Æ÷¹ÙÒÆÖ²µÄÅųⷴӦ¡£ÓëÆäËûmTORÒÖÖÆ¼ÁÏà±È£¬ÒÀάĪ˾ֻ×÷ÓÃÓÚmTORC1µ°°×£¬¶ø¶ÔmTORC2µ°°×ûÓÐÓ°Ïì¡£
4Â¥2010-05-26 09:49:40
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ aloin µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 071000ÉúÎïѧÇóµ÷¼Á£¬³õÊԳɼ¨343 +6 ССÌðÃæÍÅ 2026-03-25 6/300 2026-03-26 23:01 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] µ÷¼Á +4 èÖèÖyoyo 2026-03-26 4/200 2026-03-26 20:43 by fmesaito
[¿¼ÑÐ] 08¿ªÍ·275Çóµ÷¼Á +3 À­Ë­²»ÖØÒª 2026-03-26 3/150 2026-03-26 20:22 by barlinike
[¿¼ÑÐ] Ò»Ö¾Ô¸ÏÃÃÅ´óѧ»¯Ñ§Ñ§Ë¶307Çóµ÷¼Á +8 y7czhao 2026-03-26 8/400 2026-03-26 19:51 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] Ò»Ö¾Ô¸211ԺУ 344·Ö ¶«±±Å©Òµ´óѧÉúÎïѧѧ˶£¬Çóµ÷¼Á +3 ؼ·çѩҹ¹éÈËØ¼ 2026-03-26 3/150 2026-03-26 19:35 by Çóµ÷¼Ázz
[¿¼ÑÐ] ÉúÎïѧѧ˶£¬Ò»Ö¾Ô¸ºþÄÏ´óѧ£¬³õÊԳɼ¨338 +4 YYYYYNNNNN 2026-03-26 4/200 2026-03-26 19:00 by macy2011
[¿¼ÑÐ] 312Çóµ÷¼Á +8 Éϰ¶°ÉZJY 2026-03-22 12/600 2026-03-26 18:49 by muchong357
[¿¼ÑÐ] µ÷¼ÁÍÆ¼ö +4 Ç徯714 2026-03-26 5/250 2026-03-26 17:49 by fmesaito
[¿¼ÑÐ] 292Çóµ÷¼Á +9 ¶ì¶ì¶ì¶î¶î¶î¶î¶ 2026-03-25 10/500 2026-03-26 16:27 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 289Çóµ÷¼Á +17 ˶ÐǸ° 2026-03-23 17/850 2026-03-26 16:18 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] ¿¼Ñе÷¼Á +6 À´ºÃÔËÀ´À´À´ 2026-03-21 7/350 2026-03-25 22:43 by 418490947
[¿¼ÑÐ] ÕÐ08¿¼Êýѧ +8 laoshidan 2026-03-20 17/850 2026-03-25 17:52 by Ò»¸öºìÌ«Ñô
[¿¼ÑÐ] 302Çóµ÷¼Á +4 ½õÒÂÎÀÌÙ½· 2026-03-25 4/200 2026-03-25 16:29 by ¹¦·ò·è¿ñ
[¿¼ÑÐ] 311Çóµ÷¼Á +3 ¶¬Ê®Èý 2026-03-24 3/150 2026-03-24 21:31 by peike
[¿¼ÑÐ] Çóµ÷¼Á +5 ÁÖ֮Ϧ 2026-03-24 5/250 2026-03-24 17:16 by dick_runner
[¿¼ÑÐ] Çóµ÷¼ÁÒ»Ö¾Ô¸Î人Àí¹¤´óѧ²ÄÁϹ¤³Ì£¨085601£© +5 WW.' 2026-03-23 7/350 2026-03-24 14:50 by sprinining
[¿¼ÑÐ] 335Çóµ÷¼Á +4 yuyuÓî 2026-03-23 5/250 2026-03-23 23:49 by Txy@872106
[¿¼ÑÐ] 298Çóµ÷¼Á +8 Éϰ¶6666@ 2026-03-20 8/400 2026-03-23 11:02 by laoshidan
[¿¼ÑÐ] 306Çóµ÷¼Á +5 À´ºÃÔËÀ´À´À´ 2026-03-22 5/250 2026-03-22 16:17 by BruceLiu320
[¿¼ÑÐ] Ò»Ö¾Ô¸ ÄϾ©º½¿Õº½Ìì´óѧ´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶ +5 @taotao 2026-03-20 5/250 2026-03-20 20:16 by JourneyLucky
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û